[DOI] [PubMed] [Google Scholar] 33.McMenamin M.E., Fletcher C.D
All authors have reviewed the submitted version and agreed to publish the manuscript
Efficacy estimand This estimand is used to assess the average treatment effect of bimagrumab, semaglutide or bimagrumab plus semaglutide for all randomized participants at weeks 48 and 72 had they received at least one dose of study treatment, adhered to protocol-defined treatment and did not discontinue treatment prematurely
10.1016/0922-4106(90)90124-G 136
Circ Cardiovasc Qual Outcomes 4(4):425432 Croxford S et al (2017) Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort
Some oral formulations also come with inconvenient instructions, requiring patients to take the medication on an empty stomach with minimal water, followed by a fasting period before breakfast